Can novel adipokines, asprosin and meteorin-like, be biomarkers for malignant mesothelioma?

References

• Aydin S, Kuloglu T, Ozercan MR. 2016. Irisin immunohistochemistry in gastrointestinal system cancers. Biotech Histochem. 91:242–250. doi:10.3109/10520295.2015.1136988.
   PubMed Web of Science ®Google Scholar
• Baserga R, Hongo A, Rubini M. 1997. IGF-1 receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta. 1332:105–126.
   PubMed Web of Science ®Google Scholar
• Belardi V, Gallagher EJ, Novosyadlyy R, Roith DL. 2013. Insulin and IGFs in obesity-related breast cancer. J Mam Gland Biol Neoplas. 18:277–289. doi:10.1007/s10911-013-9303-7.
   PubMed Web of Science ®Google Scholar
• Cagle PT, Brown RW, Lebovitz RM. 1994. p53 Immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens. Hum Pathol. 25:443–448. doi:10.1016/0046-8177(94)90115-5.
   PubMed Web of Science ®Google Scholar
• Carter JH, Douglass LE, Deddens JA, Colligan BM, Bhatt TR, Pemberton JO, Konicek S, Hom J, Marshall M, Graff Jr. 2004. Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin Cancer Res. 10:3448–3456. doi:10.1158/1078-0432.CCR-03-0210.
   PubMed Web of Science ®Google Scholar
• Christensen BC, Godleski JJ, Marsit CJ, Houseman EA, Lopez-Fagundo CY, Longacker JL, Bueno R, Sugarbaker DJ, Nelson HH, Kelsey KT. 2008. Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis. 29:1555–1559.
   PubMed Web of Science ®Google Scholar
• Chunga HS, Hwang SY, Choia JH, Lee HJ, Kim NH, Yoo HJ. 2018. Implications of circulating meteorin-like (METRNL) level in human subjects with type 2 diabetes. Diabetes Res Clin Pract. 136:100–107.
   PubMed Web of Science ®Google Scholar
• Dağlı AF, Özercan MR. 2006. The role of GLUT-1 and Ki-67 in differential diagnosis of benign, premalignant and malignant lesions of endometrium. Firat Med J. 11:93–97.
   Google Scholar
• Dağlı AF. 2011. Pathological diagnosis and differential diagnosis of diffuse pleural malignant mesothelioma. J Thor Surg Spec Top. 4:50–57.
   Google Scholar
• Hwang AB, Lee SJ. 2011. Regulation of life span by mitochondrial respiration: the HIF-1 and ROS connection. Aging. 3:304–310.
   PubMedGoogle Scholar
• Ikeda K, Tate G, Suzuki T, Kitamura T, Mitsuya T. 2010. IMP3/L523S, a novel immunocytochemical marker that distinguishes benign and malignant cells: the expression profiles of IMP3/L523S in effusion cytology. Hum Pathol. 41:745–750.
   PubMed Web of Science ®Google Scholar
• Jennifer J, Hosey F, Xu H. 2010. The use of insulin like-growth factor 2 messenger RNA binding protein-3 in diagnostic pathology. Hum Pathol. 6:1–12.
   Google Scholar
• Jung TW, Kim HC, Kim HU, Park T, Park J, Kim U, Kim MK, Jeong JH. 2019. Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle. J Cell Physiol. 234:20888–20899.
   PubMed Web of Science ®Google Scholar
• Kadayıfçı A, Benekli M, Savaş C. 1994. Tumor markers. Turk Med J. 1:273–284.
   Google Scholar
• Kato Y, Tsuta K, Seki K, Maeshima AM, Watanabe S, Suzuki K, Asamura H, Tsuchiya R, Matsuno Y. 2007. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol. 20:215–220.
   PubMed Web of Science ®Google Scholar
• Kim KY, Kee MK, Chong SA, Nam MJ. 2007. Galanine colon adenocarcinoma. Cancer Epidem Biomark. 16:2373–2378.
   PubMed Web of Science ®Google Scholar
• King J, Thatcher N, Pickering C, Hasleton P. 2006. Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports. Histopathology. 49:561–568.
   PubMed Web of Science ®Google Scholar
• Kumar P, Kratzke RA. 2005. Molecular prognostic markers in malignant mesothelioma. Lung Cancer. 49:53–60.
   PubMed Web of Science ®Google Scholar
• Lee WC, Testa JR. 1999. Somatic genetic alteration in human malignant mesothelioma. Int J Oncol. 14:181–188.
   PubMed Web of Science ®Google Scholar
• Li ZY, Zheng SL, Wang P, Xu TY, Guan YF, Zhang YJ, Miao CY. 2014. Subfatin is a novel adipokine and unlike meteorin in adipose and brain expression. CNS Neurosci Ther. 20:344–354.
   PubMed Web of Science ®Google Scholar
• Marchevsky AM. 2008. Application of immunohistochemistry to the diagnosis of malignant mesothelioma. Arch Pathol Lab Med. 132:397–401.
   PubMed Web of Science ®Google Scholar
• Ordonez NG. 2003. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol. 27:1031–1051.
   PubMed Web of Science ®Google Scholar
• Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I. 2014. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. 157:1279–1291.
   PubMed Web of Science ®Google Scholar
• Romere C, Duerrschmid C, Bournat J, Constable P, Jain M, Xia F, Saha PK, Del Solar M, Zhu B, York B. 2016. Asprosin, a fasting-induced gluconeogenic protein hormone. Cell. 165:566–579.
   PubMed Web of Science ®Google Scholar
• Rowlands MA, Gunnell D, Harris R, Vatten LJ, Holly JM, Martin RM. 2009. Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer. 124:2416–2429.
   PubMed Web of Science ®Google Scholar
• Ryu TY, Park J, Scherer PE. 2014. Hyperglycemia as a risk factor for cancer progression. Diabetes Metab J. 38:330–336.
   PubMedGoogle Scholar
• Scherpereel A, Lee YC. 2007. Biomarkers for mesothelioma. Curr Opin Pulm Med. 13:339–443.
   PubMed Web of Science ®Google Scholar
• Üçer Ö, Dağli AF, Kiliçarslan A, Turk AG. 2013. Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma. Pathol J. 29:94–100.
   Google Scholar
• Wang Y, Qu H, Xiong X, Qiu Y, Liao Y, Chen Y, Zheng Y, Zheng H. 2018. Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first phase insulin secretion. Mediat Inflam. 20:2015–2017.
   Google Scholar
• Zheng SL, Li ZY, Song J, Lıu JM, Mıao CY. 2016. Metrnl: a secreted protein with new emerging functions. Acta Pharmacol Sin. 37:571–579.
   PubMed Web of Science ®Google Scholar